Slotkin Theodore A, Seidler Frederic J, Qiao Dan, Aldridge Justin E, Tate Charlotte A, Cousins Mandy M, Proskocil Becky J, Sekhon Harmanjatinder S, Clark Jennifer A, Lupo Stacie L, Spindel Eliot R
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Neuropsychopharmacology. 2005 Jan;30(1):129-44. doi: 10.1038/sj.npp.1300544.
Studies in developing rodents indicate that nicotine is a neuroteratogen that disrupts brain development by stimulating nicotinic acetylcholine receptors (nAChRs) that control neural cell replication and differentiation. We administered nicotine to pregnant Rhesus monkeys from gestational day 30 through 160 by continuous infusion, achieving maternal plasma levels comparable to those in smokers (30 ng/ml). Fetal brain regions and peripheral tissues were examined for nAChR subtypes, other neurotransmitter receptors, and indices of cell signaling and cell damage. Nicotine evoked nAChR upregulation, but with distinct regional disparities indicative of selective stimulatory responses. Similarly, indices of cell loss (reduced DNA), cell size and neuritic outgrowth (protein/DNA and membrane/total protein ratios) were distinct for each region and did not necessarily follow the rank order of nAChR upregulation, suggesting the involvement of additional mechanisms such as oxidative stress. We then attempted to offset the adverse effects of nicotine with standard dietary supplements known to interact with nicotine. By itself, choline elicited nicotine-like actions commensurate with its promotion of cholinergic neurotransmission. When given in combination with nicotine, choline protected some regions from damage but worsened nicotine's effects in other regions. Similarly, Vitamin C supplementation had mixed effects, increasing nAChR responses while providing protection from cell damage in the caudate, the brain region most susceptible to oxidative stress. Our results indicate that nicotine elicits neurodevelopmental damage that is highly selective for different brain regions, and that dietary supplements ordinarily thought to be neuroprotectant may actually worsen some of the adverse effects of nicotine on the fetal brain.
对发育中的啮齿动物的研究表明,尼古丁是一种神经致畸剂,它通过刺激控制神经细胞复制和分化的烟碱型乙酰胆碱受体(nAChRs)来破坏大脑发育。我们从妊娠第30天到160天通过持续输注给怀孕的恒河猴施用尼古丁,使母体血浆水平达到与吸烟者相当的水平(30 ng/ml)。对胎儿脑区和外周组织进行了nAChR亚型、其他神经递质受体以及细胞信号传导和细胞损伤指标的检测。尼古丁引起nAChR上调,但存在明显的区域差异,表明有选择性刺激反应。同样,每个区域的细胞损失(DNA减少)、细胞大小和神经突生长(蛋白质/DNA和膜/总蛋白质比率)指标各不相同,且不一定遵循nAChR上调的顺序,这表明还涉及其他机制,如氧化应激。然后,我们试图用已知与尼古丁相互作用的标准膳食补充剂来抵消尼古丁的不良影响。胆碱本身会引发与促进胆碱能神经传递相称的类似尼古丁的作用。当与尼古丁联合使用时,胆碱可保护一些区域免受损伤,但会加重尼古丁在其他区域的影响。同样,补充维生素C也有混合作用,增加nAChR反应,同时保护最易受氧化应激影响的脑区尾状核免受细胞损伤。我们的结果表明,尼古丁会引发对不同脑区具有高度选择性的神经发育损伤,而且通常被认为具有神经保护作用的膳食补充剂实际上可能会加重尼古丁对胎儿大脑的一些不良影响。